HomeInsightsMarket Capitalization

Market Capitalization of Novartis India Ltd

Market Capitalization of Novartis India Ltd

stocks purchased

₹ 0.3 Cr

Volume Transacted

(Nov 25, 2024)

stocks purchased

2.6 K

Stocks Traded

(Nov 25, 2024)

Last Updated on: Nov 25, 2024

Image

Novartis India Ltd

NSE: NOVARTIND

Market Cap

₹ 2537.72 crore

Last updated on: Nov 25, 2024

Key Highlights

  • The Market Cap of Novartis India Ltd is ₹ 2537 crore as of 25 Nov 24 .
  • The Market Cap of Novartis India Ltd changed from ₹ 1693 crore on March 2019 to ₹ 2539 crore on March 2024 . This represents a CAGR of 6.99% over 6 years.
  • The Latest Trading Price of Novartis India Ltd is ₹ 1027 as of 25 Nov 15:30 .
  • The Dividend Payouts of Novartis India Ltd changed from ₹ 10 on Jul 29, 2020 to ₹ 25 on Jul 23, 2024 . This represents a CAGR of 16.50% over 6 years.

Historical Market Cap of Novartis India Ltd

No data available

* All values are in crore

Company Fundamentals for Novartis India Ltd

No data available

Image

Novartis India Ltd

NSE: NOVARTIND

Share Price

₹ 1027.8

2.00 (0.19%)

stock direction

Last updated on: Nov 25, 2024

Market Price of Novartis India Ltd

1M

1Y

3Y

5Y

Monitoring Novartis India Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
25 Nov 20241027.8
22 Nov 20241025.8
21 Nov 20241024.35
19 Nov 20241022.9
18 Nov 20241034.9
14 Nov 20241061.4
13 Nov 20241054.95
12 Nov 20241072.8
11 Nov 20241049.35
08 Nov 20241079.45

SWOT Analysis Of Novartis India Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Novartis India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Novartis India Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Novartis India Ltd

No data available

No data available

Historical P/E Ratio of Novartis India Ltd

No data available

* All values are in %

Historical Revenue of Novartis India Ltd

No data available

* All values are in crore

Historical EBITDA of Novartis India Ltd

No data available

* All values are in crore

Historical Net Profit of Novartis India Ltd

No data available

* All values are in crore

Historical Dividend Payouts of Novartis India Ltd

No data available

* All values are in

About Novartis India Ltd

  • Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
  • The Company is focused on manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates in four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
  • The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
  • In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
  • In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.

Novartis India Ltd News Hub

News

Novartis India schedules board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 25 October ...

Read more

28 Sep 202410:07

News

Novartis India to declare Quarterly Result

Novartis India will hold a meeting of the Board of Directors of the Company on 29 July 202...

Read more

28 Jun 202417:50

News

Novartis India to conduct AGM

Novartis India announced that the 76th Annual General Meeting(AGM) of the company will be ...

Read more

11 May 202411:58

News

Board of Novartis India recommends Final Dividend

Novartis India announced that the Board of Directors of the Company at its meeting held on...

Read more

10 May 202417:41

News

Novartis India to conduct board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 10 May 2024...

Read more

27 Mar 202417:28

News

Novartis India Ltd leads losers in 'B' group

Pritish Nandy Communications Ltd, DB (International) Stock Brokers Ltd, Sarthak Metals Ltd...

Read more

20 Feb 202414:45

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Novartis India Ltd Market Cap

What is the market cap of Novartis India Ltd?

As of November 25, 2024, Novartis India Ltd has a market capitalization of ₹2537.72, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Novartis India Ltd's market capitalization?

Novartis India Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Novartis India Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Novartis India Ltd's market capitalization change?

Novartis India Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*